Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.651 | A Phase 1/2, Open-label, Dose-escalation, and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3S-001 Monotherapy or Combination Therapy in Subjects with Advanced Solid Tumors with a KRAS p.G12C Mutation |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2021.582 | An open label, first-in-human study of BAY 2927088 in participants with advanced non-small cell lung cancer (NSCLC) harboring an EGFR and/or HER2 mutation | Dr. LOONG Herbert Ho Fung |
| 2022.654 | A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07) | Dr. LOONG Herbert Ho Fung |
| 2021.540 | TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU (TAPISTRY) PHASE II PLATFORM TRIAL |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2023.150 | Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion, of zongertinib (BI 1810631) as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2021.497 | A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2021.456 | A Phase 1 Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Tarlatamab in Subjects With Small Cell Lung Cancer (DeLLphi-300) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2021.399 | PHASE 3 RANDOMIZED STUDY OF DS-1062A VERSUS DOCETAXEL IN PREVIOUSLY TREATED ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER WITH OR WITHOUT ACTIONABLE GENOMIC ALTERATIONS (TROPION-LUNG01) |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2022.172 | KontRASt-02: A randomized, controlled, open label, phase III study evaluating the efficacy and safety of JDQ443 versus docetaxel in previously treated subjects with locally advanced or metastatic KRAS G12C mutant non-small cell lung cancer |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2023.067 | Long-term survivorship challenges of advanced/metastatic GIST patients responding to tyrosine kinase inhibitor treatment: An observational study. | Dr. LOONG Herbert Ho Fung |
| 2023.038 | (PEAK) A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER CLINICAL STUDY OF CGT9486+SUNITINIB VS SUNITINIB IN SUBJECTS WITH LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC GASTROINTESTINAL STROMAL TUMORS | Dr. LOONG Herbert Ho Fung |
| 2022.272 | Brightline-1: A Phase II/III, randomized, open-label, multi-center study of brigimadlin (BI 907828) compared to doxorubicin as first line treatment of patients with advanced dedifferentiated liposarcoma |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2022.341 | A phase 1/1b/2 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2023.069 | A Randomized, Open-label, Phase 3 Trial of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in Treatment-naïve Subjects with Advanced or Metastatic PD-L1 High (TPS ≥50%) Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung08) | Dr. LOONG Herbert Ho Fung |
| 2022.261 | A Phase 1/2 Study of PBI-200 in Subjects with NTRK-Fusion-Positive Advanced or Metastatic Solid Tumors | Dr. LOONG Herbert Ho Fung |
| 2020.567 | A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Ifosfamide and Etoposide versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults with Relapsed or Refractory Osteosarcoma (OLIE) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.022 | A Phase 2 Precision Oncology Study of Biomarker-Directed, Pembrolizumab- (MK-3475, SCH 900475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (KEYNOTE-495; KeyImPaCT) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.477 | A Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation and Multi-cohort Expansion Clinical Study to Assess the Safety and Antitumor Activity of Niraparib in Combination with MGD013 in Patients with Advanced or Metastatic Solid Tumor Who Failed Prior Treatment | Dr. LOONG Herbert Ho-fung |
| 2014.580 | Randomized Controlled Trial on the Effectiveness of Ayres Sensory Integration Approach using by Occupational Therapist for School-aged Children with Sensory Processing Deficits | Ms. LOUIE Frances Tsui Man |
| 2010.151 | A novel approach for the non-invasive prenatal diagnosis of sex-linked disorders | Ms LOW Lisa P. L. |
| 2012.155 | Effects of an interactive eLearning Information Package (eLIP) for hospitalized older people and families to make decisions about discharge locations: A non-equivalent control group pretest and postetest design | Ms LOW Lisa P.L. |
| 2014.430 | A prospective cohort study on the effectiveness of psychological preparation conducted by Hospital Play Specialist in reducing need of sedation and level of anxiety in paediatric patients who undergo MRI | Ms LOY Tammy Sze wah |
| 2012.094 | Characterization of MicroRNA-mediated neuronal differentiation of Mesenchymal Stem Cells for Axonal Regeneration | Prof. Lu Gang |
| 2011.116 | A primate-specific miR-637 induces mesenchymal stem cell neural differentiation through RES corepressors | Prof. Lu Gang |
| 2013.169 | Study of genetic variations in predictive biomarkers of Parkinson | Prof. Lu Gang |
| 2013.216 | Characterization of MicroRNA-mediated neuronal differentiation of Mesenchymal Stem Cells for Axonal Regeneration | Prof. Lu Gang |
| 2020.488 | Decoding the cognitive trajectory of Hong Kong SuperAgers: a six-year follow-up study | Dr. LU Hanna |
| 2024.652 | Focused low-intensity hippocampal transcranial ultrasound stimulation (TUS) for modulating the glymphatic function and cognition in mild neurocognitive disorder due to Alzheimer’s disease: a randomized clinical trial | Dr. LU Hanna |
| 2025.118 | Personalized assessment of high-definition slow-oscillatory transcranial direct current stimulation (so-tDCS) in older adults with subjective cognitive and sleep complaints | Dr. LU Hanna |
| 2023.636 | A pilot randomized controlled trial of MRI-guided focused low-intensity transcranial ultrasound stimulation (TUS) for sleep disturbances in patients with chronic tinnitus | Dr. LU Hanna |
| 2023.496 | Hong Kong Cohort of Abnormal Sleep in Ageing Population (HK-ASAP): an observational study on sleep quality, brain reserve and cognitive phenotypes in community-dwelling older adults | Dr. LU Hanna |
| 2023.074 | A pilot randomized controlled trial of MRI-informed high-frequency transcranial random noise stimulation (hf-tRNS) for sleep disturbance and cognitive dysfunction in mild vascular cognitive impairment | Dr. LU Hanna |
| 2020.631 | Gamma-band high-definition transcranial alternating current stimulation (HD-tACS) for sleep disturbances in mild neurocognitive disorders due to Alzheimer’s disease | Dr. LU Hanna |
| 2023.171 | Simulation-informed modelling and personalized evaluation (SIMPLE): An MRI-based brain age matrices for predicting cognitive maintenance and healthy longevity | Dr. LU Hanna |
| 2021.658 | Development of a personalized turn-key solution to evaluate the treatment outcomes and adverse effects of slow-oscillatory transcranial direct current stimulation (so-tDCS) in elderly with subjective cognitive complaints | Dr. LU Hanna |
| 2014.048 | Would attention network function differentiate between healthy aging and mild neurocognitive disorder due to Alzheimer's disease (MND-AD)? | Ms Lu Hanna |
| 2015.625 | Objective ways to assess the fetal facial profile features using 2D and 3D ultrasound |
Ms. LU Jing 路晶 |
| 2017.644 | Pitfalls in assessing chorioamnionicity: novel observations and literature review |
Ms. LU Jing 路晶 |
| 2025.183 | The effects of a psycho-behavioural intervention on cancer-related fatigue in patients with colorectal cancer: A randomised controlled trial |
Ms. LU Jinling 陆金玲 |
| 2014.388 | Observational study on risk factors of recurrence after breast-conserving surgery for Chinese early-stage breast cancer patients | Miss LU Qianyun |
| 2016.381 | Comparison of the Role of Whey Protein and Alpha-lactalbumin in Recovery of Muscle Damage, Muscle Soreness and Affective Responses after Strenuous Prolonged Endurance Exercise |
Ms. LU Qin 覃璐 |
| 2016.583 | Comparison of the pre-exercise ingestion effect between whey PRO and alpha-lactalbumin on substrate metabolism, muscle damage, affective responses and subsequence exercise performance |
Ms. LU Qin 覃璐 |
| 2009.466 | Prospective and controlled study on medial arch suppport in long distance running, comparing flat insole and tailor made medial arch support insole, by plantar pressure distribution and lower limb electromyogram | Mr LUE BO KONG |
| 2022.431 | A Phase II/III, Double-Blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients with Moderate to Severe COVID-19 |
Dr. LUI Grace Chung Yan 雷頌恩 |
| 2020.336 | Prospective Study on Sessile Serrated Adenoma/Polyps in the Colorectum | Dr. LUI Abdul Rashid N.S. |
| 2020.467 | A retrospective territory-wide cohort study to determine the incidence of bacterial infections, antibiotics consumption, and the role of procalcitonin in antibiotic stewardship among patients with COVID-19 |
Prof. LUI Chung Yan 雷頌恩 |
| 2022.326 | Automatic retinal image analysis (ARIA) for risk stratification of coronary artery disease risk in people living with HIV |
Prof LUI CHUNG YAN Grace 雷頌恩 |
| 2025.144 | A prospective study to evaluate the efficacy of glucagon-like peptide-1 agonist in the prevention and management of metabolic dysfunction-associated steatotic liver disease in obese type 2 diabetes mellitus patients | Dr. LUI Edmond Yat Man |
| 2021.310 | Exercise and dietary counselling programme for people living with HIV with sarcopenia: A randomized controlled trial |
Dr. LUI Grace C. Y. 雷頌恩 |
| 2023.503 | A cluster-randomized controlled pragmatic trial to evaluate antimicrobial stewardship strategies for short-course and oral-switch antibiotic therapy for bloodstream infections due to Enterobacterales | Dr. LUI Grace C.Y. |
Page 161 of 265.